Pinnacle Wealth Management Advisory Group’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,020	Closed	-$208K	–	405
2025 Q2	$208K	Sell	3,020 -44	-1%	-$2.99K	0.02%	353
2025 Q1	$213K	Buy	3,064 +44	+1%	+$3.63K	0.02%	339
2024 Q4	$260K	Hold	3,020	–	–	0.02%	305
2024 Q3	$360K	Hold	3,020	–	–	0.03%	247
2024 Q2	$431K	Hold	3,020	–	–	0.04%	212
2024 Q1	$388K	Hold	3,020	–	–	0.04%	223
2023 Q4	$312K	Buy	3,020 +18	+0.6%	+$1.78K	0.04%	235
2023 Q3	$273K	Hold	3,002	–	–	0.04%	246
2023 Q2	$243K	Buy	3,002 +34	+1%	+$2.78K	0.03%	277
2023 Q1	$236K	Buy	+2,968	New	+$210K	0.03%	271
2016 Q3	–	Sell	-8,800	Closed	-$237K	–	122
2016 Q2	$237K	Hold	8,800	–	–	0.19%	104
2016 Q1	$238K	Hold	8,800	–	–	0.21%	96
2015 Q4	$256K	Hold	8,800	–	–	0.23%	89
2015 Q3	$239K	Hold	8,800	–	–	0.23%	83
2015 Q2	$241K	Buy	8,800 +1,000	+13%	+$28.1K	0.22%	90
2015 Q1	$208K	Buy	+7,800	New	+$180K	0.19%	100